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Abstract 
When injected into mice prior to the NO generation i crease induced with lipopolysaccharide (LPS) from Escherichia coli, exogenous 
antioxidants diethyldithiocarbamate (DETC) or phenazan (sodium 3.5-di-tert-butyl-4-oxiphenylpropionate) as well as the inhibitor of 
protein biosynthesis, cycloheximide (CHI) attenuated the NO production in mouse liver in vivo. These data demonstrated the key role of 
free radicals, which were likely, active oxygen species, in the synthesis of inducible NO-synthase (iNOS) responsible for the NO 
production in this organ. Similar effects of phenazan and CHI were observed in livers of mice treated with T-irradiation or 
LPS + Fe2+-citrate, which suggested that these treatments also induced 1NOS synthesis through initiating the action of active oxygen 
species. The rate of NO synthesis was estimated by accumulation of paramagnetic mononitrosyl iron complexes with DETC 
(MNIC-DETC) detected using the EPR method. The formation of MNIC-DETC complexes was found in the brain of mice pre-treated 
with LPS + Fe2+-citrate which seemed to be due to iNOS synthesis timulated by this treatment. 
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1. Introduction 
It has been recently shown that dithiocarbamates, in-
hibitors of the nuclear transcription factor K B (NFKB) 
prevent synthesis of inducible NO synthase (iNOS) in 
renal mesangial cells treated with interleukin 1 or tumour 
necrosis factor a ,  as wel)l as in murine alveolar and bone 
marrow-derived macrophage cells stimulated with bacterial 
l ipopolysaccharide (LPS) and interferon- , / ( INF- , / )  [1-3]. 
These data demonstrated the key role of active oxygen 
species in this iNOS biosynthesis, inactivated with well- 
known antioxidants, dithiocarbamates. 
In the present study similar investigations were under- 
Abbreviations: DETC, Diethyldithiocarbamate; EPR, electron para- 
magnetic resonance; HFS, hyperfine structure; INF-3,, interferon-T; L- 
NNA, NG-nitro-L-arginine; LPS, lipopolysaccharide from Escherichia 
coli; MNIC*DETC, mononitrosyl iron complex with DETC; NO, nitric 
oxide; cNOS or iNOS, constitutive or inducible NO synthase, respec- 
tively; PDTC, pyrrolidine dithiecarbamate. 
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taken on the animal organism. There, the effects were 
studied of diethyldithiocarbamate (DETC) and of another 
antioxidant, phenazan as well as the action of a protein 
biosynthesis nhibitor, cycloheximide (CHI) on NO synthe- 
sis induced by bacterial LPS or T-irradiation via the L- 
arginine-dependent pathway in mouse liver in vivo [4-6]. 
,/-Irradiation is well known to produce active oxygen 
species in animal tissues. Therefore we proposed that these 
species can induce iNOS synthesis through the transduc- 
tion pathway similar to that stimulated with bacterial LPS. 
To detect NO in mouse liver we used a method based 
on utilizing a complex of Fe 2÷ with DETC as an exoge- 
nous ligand. Fe2+-DETC complex acts as a specific trap 
for NO and forms with it paramagnetic mononitrosyl 
complexes (MNIC-DETC). This complex is characterized 
by an EPR signal at g x = 2.035 and gll = 2.02 with a 
triplet hyperfine structure (HFS) at g ± [7]. This approach 
makes it possible to demonstrate and quantify NO forma- 
tion in animal organs in vivo following various pretreat- 
ments [4-6]. Thus in our experiments DETC was used as 
both an antioxidant and a ligand component of MNIC. 
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2. Materials and methods 
2.1. Materials 
Lipopolysaccharide (LPS) from Escherichia coli (sero- 
type 005:B5), cycloheximide (CHI), and NC-nitro-L - 
arginine (L-NNA) were all from Sigma. NaNO 2, sodium 
diethyldithiocarbamate (DETC), sodium citrate and 
FeSO 4 • 7H20 were obtained from Serva. Sodium dithion- 
ite was from Merck. A water-soluble antioxidant phenazan 
(sodium 3,5-di-tert.-butyl-4-oxiphenylpropionate) was a 
generous gift of Prof. V.V. Ershov and Dr. L.G. 
Plekhanova. Gaseous NO was obtained by the reaction of 
FeSO 4 and NaNO 2 in acid environment (0.1 M HC1) and 
then purified by fractional sublimation in a high-vacuum 
system (P  < 0.01 mmHg). 
2.2. Sample preparation 
Experiments were carried out on white mongrel male 
mice (20-22 g) in February-April. All agents were in- 
jected into mice in 0.2 ml of physiological saline intraperi- 
toneally (i.p.) (CHI, DETC, L-NNA, NaNO 2 or phenazan) 
or subcutaneously in the thigh (Fe2+-citrate complex) at 
the following doses: DETC, 500 mg/kg;  FeSO4.7H20,  
37.5 mg/kg;  citrate-Na, 187.5 mg/kg;  CHI, 3 mg/kg ;  
NaNO 2, 50 mg/kg;  phenazan, 100 mg/kg;  L-NNA, 250 
mg/kg  (administration terms are shown in the text below). 
After decapitation of the animals, the liver and the brain 
were isolated, frozen in liquid nitrogen, and analyzed with 
an EPR-V (Russia) or an ESR-'Radiopan' (Poland) ra- 
diospectrometer. In some experiments the tissues isolated 
from mice were treated with gaseous NO (300 mmHg). To 
this aim, isolated tissue was placed into a closed vessel. 
After evacuation, the vessel was filled with NO gas at 300 
mmHg for 30 min. The NO was pumped out and the tissue 
was frozen in liquid nitrogen for EPR analysis. One group 
of mice was also subjected to y-irradiation from a 6°Co- 
source at a sublethal dose (700 Rt~ntgen) for 10 min. 
Special experiments have shown that of 30 mice exposed 
to such irradiation, 20 survived a month (~ 70%). A 
solution of 57Fe to be injected subcutaneously into mouse 
upper leg was prepared as follows. A powder of 57Fe203 
was heated with H2SO 4 + H20 (8:3) in a glass test tube 
on a water bath until decoloration (~ 10 h). The concentra- 
tion of 57Fe3+ was adjusted to 1 mg/ml  (pH 3-4), and the 
solution was stored in a refrigerator. Before injection into 
the animals, sodium citrate (3.75 mg in 0.2 ml) was added, 
increasing the pH to 6. Then sodium dithionite was added 
until decoloration to reduce 57Fe3+ to57Fe 2+, and this 
solution was used for the injection. 
2.3. EPR spectrometry 
EPR spectra were recorded at 77 K, the microwave 
frequency of 9.330 GHz, the microwave power of 5 mW, 
and the modulation amplitude of 0.5 mT. Quantification of 
MNIC-DETC complexes was accomplished using the com- 
parision of the amplitudes of EPR signals with those of a 
standard MNIC-DETC complex of known concentration 
prepared in dimethylsulfoxide solution as described else- 
where [7]. 
3. Results 
3.1. Effects of  antioxidants and CHI on NO formation 
induced with LPS in mouse liver in vivo 
LPS from E. coli induced NO generation in mouse 
liver after 3.5-4 h of its administration to mice. The 
method used in this investigation permitted estimation of 
the rate of MNIC-DETC complex formation over 30 min, 
i.e., the rate of NO formation which could be trapped over 
this time by the Fe2+-DETC complexes. It is noteworthy 
that our method will only quantify the relative concentra- 
tions of NO within the tissues because not all of the NO 
which has been formed by the tissue is evidently included 
into MNIC-DETC complex. 
The rate of MNIC-DETC complex formation increased 
from 1 nmol /g  of wet liver tissue/30 min in control mice 
to 18 nmol /g  of wet l iver/30 min in mice pretreated with 
LPS (Table 1). This rate was constant between 3.5 and 9.5 
h after the LPS administration but then it returned to the 
control level at 15 h (not shown). The values of these rates 
Table 1 
Quantification f MNIC-DETC complexes formed in the liver of mice 
treated with DETC, Fe2+-citrate complex (Fe), phenazan orCHI at the 
doses indicated inSection 2
Treatment MNIC-DETC 
complex 
formation over 
30 min of 
(nmol/g of wet 
liver tissue) 
DETC (0.5 h)-decap. 1 __+ 1 
DETC, Fe (0.5 h)-decap. 3 _+ 1 
LPS (4.5 h) + DETC (0.5 h)-decap. 18 ___ 4 
LPS (4.5 h) + DETC,Fe (0.5 h)-decap. 460 + 20 
LPS,phenazan (4.5 h)+DETC (0.5 h)-decap. 1 + 1 
LPS (6 h) + DETC (2 h)-decap. 1 + 1 
LPS (4.5 h)+DETC (3.5 h)+DETC (0.5 h)-decap. 0.8+0.3 
LPS (6.5 h)+ DETC (2.5 h)+DETC (0.5 h)-decap. 13 -t-2 
LPS (4.5 h) + CHI (2 h) + DETC (0.5 h)-decap. 6 + 2 
LPS (9 h)+ DETC (0.5 h)-decap. 20_ 5 
LPS (9 h) + DETC,Fe (0.5 h)-decap. 430_+ 20 
LPS (9 h)+CHI (2 h)+DETC (0.5 h)-decap. 20+5 
LPS (9 h)+CHI (2 h)+ DETC,Fe (0.5 h)-decap. 200+20 
Data shown are expressed asmean + S.E. of 5-20 individual observations 
from different mice (* P < 0.01 versus corresponding different animals). 
Time between the reagent administrations and decapitation (decap.) of 
animals is given in brackets. 
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Fig. 1. Typical EPR spectra of mouse liver preparations from a control 
animal injected with DETC (b), an animal injected with LPS (4 h) + DETC 
(c), an animal injected with LPS (4 h)+DETC+56Fe2+-citrate (d) or 
57Fe?+-citrate ( ) complexes. (a,f) EPR spectra of MNIC-DETC com- 
plexes in dimethylsulfoxide solution, including 56Fe (a) or 57Fe (f). The 
MNIC-DETC complex gives an EPR signal at g ± = 2.035, gll = 2.02. 
The EPR signal at g = 1.94 i~ due to reduced iron-sulfur proteins. 
Records were made at 77 K, ~c,= 5 mW, f= 9.330 GHz, modulation 
amplitude = 0.5 mT. Relative gain settings of the spectrometer are shown 
at the right side of spectra. 
were estimated by the intensities of EPR signals from 
MNIC-DETC complexes, which are presented in Fig. 1. 
DETC administration to the animals did not practically 
affect the NO formation in mouse liver if DETC was 
injected into mice during the period of elevated LPS-in- 
duced NO synthesis. This was demonstrated by the experi- 
ments when DETC was injected into mice 4 h after LPS 
treatment and 2.5 h before decapitation (Table 1, line 8). 
However, DETC completely inhibited the effect of LPS 
treatment of mice on the NO formation when it was 
injected into mice 1 h after LPS administration, i.e., prior 
to the LPS-induction of iNOS (Table 1, line 7). It is worth 
noting that administration of DETC to the animals for 2 h 
prior to decapitation within the period of elevated NO- 
synthesis (without the additional DETC injection) did not 
lead to the accumulation of MNIC-DETC in mouse liver 
(Table 1, line 6). Evidently these complexes were decom- 
posed by this time and the additional DETC injection for 
30 min was required to synthesize new MNIC-DETC 
(Table 1, line 8). The inhibitory effect of DETC on 
MNIC-DETC formation observed in our experiments 
seemed to be due to antioxidant properties of DETC. A 
similar effect was obtained for another antioxidant 
phenazan when it was injected into mice simultaneously 
with LPS (Table 1, line 5). 
The attenuated formation of MNIC-DETC complexes in 
livers of mice following administration of these anti- 
oxidants might have been caused by a decrease in the 
amount of NO traps (Fe2+-DETC complexes) available in 
the animal tissue. To verify this hypothesis we investigated 
the effect of administration of DETC or phenazan to mice 
(1 h after LPS or simultaneously with LPS, respectively) 
on MNIC-DETC complex formation induced by NO ex- 
ogenous donor NaNO 2 (50 mg/kg)  in the liver. The NO 
formation from NaNO 2 in animal organisms has been 
demonstrated arlier by formation of nitrosyl hemoglobin 
or MNIC-DETC complexes [5,8]. No influence of DETC 
or phenazan on the MNIC-DETC complex formation was 
observed in these experiments (data not shown). 
Similar results were obtained in experiments with CHI 
administration to mice. The CHI treatment of mice 2.5 h 
after LPS administration resulted in the attenuation of NO 
formation in mouse liver (Table 1, line 9). This was not 
the case when CHI was administrated after the induction 
of iNOS with LPS (Table 1, line 12). Experiments using 
NaNO 2 as an exogenous donor of NO showed that CHI 
administration to animals did not affect the amount of NO 
traps, Fe2+-DETC complexes (data not shown). 
3.2. Effects of phenazan and CHI on the hepatic NO 
formation induced with y-irradiation in mice 
3,-Irradiation of mice at a dose of 700 RiSntgen potenti- 
ated the MNIC-DETC complex formation in the liver 
(Table 2, lines 2 and 7). This effect was observed in 2-15 
h, whereafter the rates of MNIC-DETC formation de- 
creased (not shown). CHI or phenazan treatments before or 
immediately after y-irradiation resulted in the attenuation 
Table 2 
Quantification of MNIC-DETC complexes in livers of CHI -or  
phenazan-treated mice under y-irradiation (3'-) 
Treatment MNIC-DETC complexes 
formation over 30 min 
(nmol/g of wet 
liver tissue) 
DETC (0.5 h)-decap 2.3 +0.3 
3'-(4.5 h)+ DETC (0.5 h)-decap. 9.0 + 1.0 
Phenazan, 3'-(4.5 h)+ DETC (0.5 h)-decap. 3.3 + 1.3 
CHI (6 h)+ 3'-(4.5 h)+DETC (0.5 h)-decap. 1.4+0.3 
7-,CHI (4.5 h) + DETC (0.5 h)-decap. 2.1 + 0.7 
3,-(6 h) + CHI (2 h) + DETC (0.5 h)-decap. 5.5 + 1.3 
3'-(7.5 h)+ DETC (0.5 h)-decap. 7.3 _+ 1.6 
3'-(7.5 h)+CHI (2 h)+DETC (0.5 h)-decap. 8.2+_2.3 
3'-,CHI (7.5 h)+DETC (0.5 h)-decap. 2.1 _+0.5 
Data shown as the mean + S.E. of 5-15 observations from different mice 
(* P < 0.01 versus corresponding different animals). Time between 3'- 
irradiation with reagent administration a d decapitation (decap.) is given 
in brackets. 
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of MNIC-DETC formation (Table 2, lines 3-6 and 9). The 
increase in the interval between y-irradiation and the fol- 
lowing CHI administration to mice led to diminishing the 
CHI effect. For example, if CHI was administrated to mice 
5.5 h after y-irradiation for 2 h prior to decapitation of 
animals, no influence of this agent on the MNIC-DETC 
complex formation was observed (Table 2, line 8). 
Pretreatment of mice with LPS changed the effect of 
y-irradiation on the NO formation in mouse liver, y-Irradi- 
ation potentiated the MNIC-DETC complex formation if 
the LPS pretreatment of animals stimulated the formation 
of MNIC-DETC complex at rates below 3 nmol of 
MNIC-DETC/g of wet l iver/30 min. On the contrary, 
y-irradiation diminished the MNIC-DETC complex forma- 
tion if the LPS pretreatment stimulated this formation with 
the rates above 20 nmol of MNIC-DETC/g of wet l iver/30 
min. 
3.3. The effect of  CHI on the increase in LPS-induced NO 
formation with Fe 2 +-citrate in mouse liver 
Administration of the Fe2+-citrate complex to mice 30 
min prior to decapitation i the period of elevated LPS-in- 
duced NO synthesis harply increased the rates of MNIC- 
DETC formation (Table 1, lines 4 and 11). This effect 
might be solely due to an increase in the content of NO 
traps, the Fe2+-DETC complexes. Results of experiments 
with injections of 57Fe2+-citrate complexes into mice were 
in line with this proposition. If 57Fe were to be included in 
the MNIC-DETC complex, its EPR signal would be char- 
acterized with an HFS originating from interaction of the 
unpaired electron with the 57Fe nucleus (its spin, I = 1/2) 
[7]. Such HFS was recorded in the EPR signal from the 
MNIC-DETC complex formed in the liver of mice treated 
with LPS +57Fe2+-citrate (Fig. 1). This result demon- 
strated that exogenous iron can form Fe2+-DETC com- 
plexes as endogenous iron, thereby increasing the content 
of these NO traps in the mouse liver. Nevertheless, when 
CHI was administrated to mice 7 h after the LPS treat- 
ment, the effect of Fe2+-citrate complex administration on 
the MNIC-DETC formation diminished two-fold (Table 1, 
line 13). These findings indicate that the increase in the 
rate of MNIC-DETC complex formation induced by the 
Fe2+-citrate complex might be partially caused by the 
elevation of NO generation due to iNOS induction. 
Administration of Fe2+-citrate to non-LPS-pretreated 
mice increased the MNIC-DETC complex formation in 
mouse liver as well but its rate was much lower than that 
in the animals pretreated with LPS (Table 1, line 2). 
3.4. MNIC-DETC complex formation in mouse brain stim- 
ulated with LPS and Fe e +-citrate 
LPS also induced the formation of NO in mouse brain 
within 3.5-4 h of its administration to the animals. The 
g " 2.038 2.00 
11 
B 
t94  
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Fig. 2. Typical EPR spectra of a mouse brain preparations from an animal 
injected with DETC (a), an animal injected with DETC+Fe2+-citrate 
complex (b), an animal injected with LPS (4 h)+DETC+Fe2+-citrate 
complex (c). The MNIC-DETC complex gives an EPR signal at g ± = 
2.035, gll = 2.02 and triplet HFS. The EPR signal at g = 1.94 is due to 
reduced iron-sulfur proteins. The EPR signal at g = 2 is the third 
component of HFS in the EPR signal due to Cu2+-DETC complex. 
Recording conditions are the same as indicated in Fig. 1. 
rate of MNIC-DETC complex formation was 10 ___ 2 nmol 
of MNIC-DETC/g of wet brain tissue/30 min (n = 5). 
However, this formation was observed only if Fe2+-citrate 
complex was injected into animals simultaneously with 
DETC. The Fe2+-citrate + DETC administration to non- 
LPS-pretreated mice stimulated the MNIC-DETC complex 
formation at the rate of 2 + 1 nmol of MNIC-DETC/g of 
wet brain tissue/30 min (n = 5). Without the Fe2+-citrate 
administration, the MNIC-DETC complex formation was 
observed neither in the brains of animals pretreated with 
LPS nor in the brains of untreated mice. The formation of 
DETC complexes with endogenous copper (Cu 2+) was 
detected only in these preparations. Typical EPR spectra 
from the brains of mice treated with LPS, DETC, and 
Fe2+-citrate are shown in Fig. 2. 
The dministration of L-NNA, the NOS inhibitor, to 
mice 30 min before the addition of Fe2+-citrate complex + 
DETC completely inhibited the MNIC-DETC complex 
formation in mouse brain (not shown). This result indi- 
cated that the formation of NO in mouse brain was in- 
duced via the L-arginine-dependent pa hway; CHI adminis- 
tration did not influence the NO formation in mouse brain. 
MNIC-DETC complexes were formed in mouse brain 
when NaNO 2 (50 mg/kg)  was administrated to mice as an 
exogenous ource of NO. The rate of this formation was 
2.5 + 0.5 nmol of MNIC-DETC/g of wet brain tissue/30 
min (n = 5). The administration of Fe2+-citrate complex to 
these animals increased this rate 4-fold. The treatment of 
brain samples with gaseous NO increased the content of 
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MNIC-DETC to 30_  5 nmol of MNIC-DETC/g of wet 
brain tissue (n = 3) and to 50+ 10 nmol of MNIC- 
DETC/g of wet brain tissue (n = 3) isolated from the 
animals not treated with Fe2+-citrate or treated with Fe 2+- 
citrate respectively. 
4. Discussion 
The induction of iNOS biosynthesis with LPS in animal 
liver in vivo has been demonstrated arlier by the increase 
of NO formation [4,5], the accumulation of NO~- and 
NO 3, the final products of NO oxidation [9,10], and by the 
expression of iNOS mRNA [11] in this organ. The data 
obtained in the present study allow us to propose that the 
regulation of iNOS biosynthesis in mouse liver may in- 
clude the formation of active oxygen species initiating this 
protein synthesis. Our experiments are in line with those 
concerning the influence of antioxidants, dithiocarbamate 
derivatives, on the NO production by macrophage cells 
activated with LPS or LPS + INF-y [1,2] or by renal 
mesangial cells treated with interleukin 1or tumor necrosis 
factor [3]. Inhibition of this process with pirrolidine dithio- 
carbamate (PDTC) or DETC in cultured cells was sug- 
gested to be caused by the active oxygen species-scaveng- 
ing effect of these antioxidants. They prevented the activa- 
tion of NF-KB involved in the signal transduction pathway 
which links stimulation of macrophage or mesangial cells 
by bacterial endotoxin or cytokines with transcription of 
the gene encoding iNOS. It is noteworthy that PDTC 
interfered with induction of NOS rather than its catalytic 
activity: this antioxidant affected the NO production in 
macrophage c lls being added only prior to the NO genera- 
tion increase induced by LPS + INF-3, [1]. Similar results 
were obtained for CHI treatment of cells [2]. In our 
experiments DETC and CHI affected the NO production in 
livers of mice in a similar way. They attenuated the NO 
formation in mouse liver being added to the animals prior 
to the LPS-induced elevation of NO synthesis. However, 
neither DETC or CHI affected the NO formation in this 
organ when administered to mice during the increased NO 
generation. These results allow us to suggest that DETC as 
well as CHI operated only as an inhibitor of iNOS synthe- 
sis, but left the enzyme activity in mouse liver in vivo 
unaffected. 
The antioxidant activity of DETC is primarily due to its 
capacity to bind ions of transition metals that catalyze 
formation of an active oxygen species [12]. In cells and 
tissues, however, DETC can act as a pro-oxidant as well. 
This is provided by its ability to chelate copper from the 
active center of copper-containing superoxide dismutase 
(SOD) [13]. According to the data reported in [13], the 
administration of DETC (1500 mg/kg) to mice for 3 h 
decreased the SOD activhy by 40% in the whole liver. 
Inactivation of the enzyme nhanced the amount of super- 
oxide anion which easily oxidize NO molecules. There- 
fore, the decrease in hepatic MNIC-DETC observed in the 
liver on the DETC administration 1 h after LPS injection 
(Table I, line 7) could be due to the decrease in NO 
readily transforming into peroxinitrites in the reaction with 
O[ [14] rather than to the blockade of iNOS biosynthesis. 
This hypothesis i  in disagreement with the results of 
experiments on DETC administration during the potentia- 
tion of NO generation by iNOS. Additional (for 2 h) 
administration of DETC did not practically decrease the 
MNIC-DETC level in murine liver (Table 1, lines 3 and 
8). It seems that the decreased SOD activity resulting from 
the administration of DETC dose (500 mg/kg) was not 
sufficient o induce a considerable decrease in NO at the 
expense of NO reaction with 02 . Therefore in our experi- 
ments DETC acted primarily as an antioxidant. 
The inhibitory effect of DETC and of another antioxi- 
dant phenazan on the LPS-induced NO formation in mouse 
liver supports the proposition about the key role of active 
oxygen species in iNOS biosynthesis n this organ in vivo, 
which seem to act through the activation of NFK B. Obvi- 
ously, this conclusion about the integrating role of active 
oxygen species in this NFKB-inducing signal also holds 
true for the effect of y-irradiation on the NO formation in 
mouse livers in vivo. According to our data phenazan and 
CHI inhibited this process. The evidence that the Fe 2+- 
citrate complex, another prooxidant agent, is capable of 
inducing iNOS biosynthesis i  rather obscure. Our data 
demonstrate hat exogenous iron may elevate the content 
of NO traps, thereby increasing the efficiency of NO 
trapping by these complexes. However, the inhibitory ef- 
fect of CHI administration on these animals indicates that 
Fe2÷-citrate may partially induce the increase of NO gen- 
eration through iNOS induction. 
It has recently been shown that another prooxidant 
agent pyrogallol stimulates the synthesis of iNOS mRNA 
in cultured human epithelial cells [15]. The iNOS mRNA 
level was seen to increase in a time- and concentration-de- 
pendent fashion, with a maximum at 1-2 h. 
Obviously, LPS can also stimulate iNOS synthesis in 
the brain of mice. The main evidence for this was that the 
MNIC-DETC complex formation was potentiated by LPS 
after a long lag period, 4 h after the LPS treatment. This 
conclusion is in line with the data obtained by other 
authors [16,17], who observed an increase in iNOS mRNA 
level in the brains of animals treated with various agents. 
The administration of the Fe2+-citrate complex was 
obligatory for the MNIC-DETC complex formation in the 
brain of adult mice. This administration could sharply 
increase the amount of NO traps (Fe2+-DETC complexes) 
available in mouse brain, thereby enhancing the probability 
of NO trapping by these complexes. Concurrently exoge- 
nous iron could potentiate NO synthesis in the brain tissue 
by a mechanism which was similar to that in mouse liver. 
This was especially the case when the animals were treated 
with LPS followed by Fee +-citrate administration. The rate 
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of MNIC-DETC complex formation in mouse brain reached 
10 nmol /g  of wet brain t issue/30 min. It was equal to the 
rate of MNIC-DETC complex formation in mouse brain 
induced by injections of NaNO 2 (50 mg/kg)  + DETC + 
Fe2+-citrate into animals. Without the administration of 
Fe2+-citrate complex, NaNO 2 induced the MNIC-DETC 
complex formation at a 4-fold lower rate. Therefore, if 
administration of the Fe2+-citrate complex to mice had 
only increased the efficiency of NO-trapping in LPS-pre- 
treated animals, the MNIC-DETC complex formation 
would have been observed in the brains of mice without 
the Fe2+-citrate administration ata 4-fold lower rate. Since 
this was not the case, we suggest hat the administration of
Fe2+-citrate complex to mice pretreated with LPS induces 
both an increase in the amount of NO traps in the brain 
and a rise in the production of NO from endogenous 
sources. 
The results of our experiments with CHI administration 
to mice made it impossible to suggest hat the increase in 
NO formation in mouse brain induced by Fe2+-citrate 
injection was due to iNOS synthesis in this tissue. The 
absence of CHI effects on NO formation in mouse brain 
may be explained by the inability of CHI to penetrate into 
brain tissue in vivo. 
The appearance of MNIC-DETC complexes in the brain 
(10 nmol /g )  might have been caused by blood transfer of 
a small part of these complexes from the liver or other 
tissues to the brain. However, in the blood from mice 
pre-treated with LPS and Fe2+-citrate complex, the rate of 
MNIC-DETC complex formation has been recently shown 
not to exceed 0.5 nmol /ml  of b lood/30  min [5]. The 
absence of correlation between the effects of CHI on the 
content of MNIC-DETC complexes in the liver and the 
brain is another argument against he forementioned propo- 
sition. 
An important role of exogenous Fe 2+ ions in the NO- 
trapping in rat brain has been previously emphasized 
[18,19]. Those authors observed a rapid increase in NO 
formation in this tissue induced by cerebrale ischemia. 
However,according to the data reported in Ref. [20], a 
requirement for injection of exogenous iron to observe the 
formation of the MNIC-DETC complexes in the brain of 
kainate-injected rats was not necessary. Therefore, this 
problem remains obscure. 
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